TrianglePUBLICATIONS · 1383436
Phase II study of estramustine and vinblastine, two microtubule inhibitors, in hormone-refractory prostate cancer.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 1992 Nov
- First author
- Hudes GR
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Hudes GR
- type
- Author
- name
- Greenberg R
- type
- Author
- name
- Krigel RL
- type
- Author
- name
- Fox S
- type
- Author
- name
- Scher R
- type
- Author
- name
- Litwin S
- type
- Author
- name
- Watts P
- type
- Author
- name
- Speicher L
- type
- Author
- name
- Tew K
- type
- Author
- name
- Comis R
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Hudes GR
- type
- Author
- name
- Greenberg R
- type
- Author
- name
- Krigel RL
- type
- Author
- name
- Fox S
- type
- Author
- name
- Scher R
- type
- Author
- name
- Litwin S
- type
- Author
- name
- Watts P
- type
- Author
- name
- Speicher L
- type
- Author
- name
- Tew K
- type
- Author
- name
- Comis R
- type
- Author
- bibliography ids
- nci-bib-235600830aa5f4f4f249b24c
- book metadata
- content sha256
- fd5186a68ba01efbae82735c715f1e74f60a82f311536f6dc78289093873d877
- document type
- citation
- dois
- 10.1200/JCO.1992.10.11.1754
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:1383436
- immutable id
- pubmed:1383436@fd5186a68ba01efbae82735c715f1e74f60a82f311536f6dc78289093873d877
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- Source null
- issn print
- 0732-183X
- issue
- 11
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 1754-61
- volume
- 10
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 1383436
- provenance
- batch id
- a0a1edf07d2c8b32d054
- provider
- NCBI PubMed ESummary
- record sha256
- 334e98d944b570e52115ea1966fcb45e43d40eeeafc5b0f5b863a78b78d53181
- response sha256
- 963b26e86e4619ee230bdf4421d4a6bcc6f03eee0a79718c660c7d40a3c066da
- retrieved at
- 2026-09-09T23:45:05.141944+00:00
- publication date
- display
- 1992 Nov
- precision
- month
- year
- 1992
- publication types
- Clinical Trial
- Clinical Trial, Phase II
- Journal Article
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- source url
- https://pubmed.ncbi.nlm.nih.gov/1383436/
- title
- Phase II study of estramustine and vinblastine, two microtubule inhibitors, in hormone-refractory prostate cancer.
Preserved source evidence · Not medical advice